You just read:

Janssen Inc. Receives Health Canada Approval of DARZALEX® (daratumumab) by Priority Review for Patients with Multiple Myeloma Who Have Had At Least One Prior Therapy

News provided by

Janssen Inc.

Apr 17, 2017, 07:30 ET